Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06314152Not ApplicableCompleted

3-point With 1-point Mesh Fixation in TAPP for Inguinal Hernia

Role: collaborator

NCT06061068Not ApplicableCompleted

Hernia Belt in Laparoscopic Inguinal Hernia Repair

Role: collaborator

NCT05929378Not ApplicableCompleted

A Comparative Study of 3-point With 1-point Mesh Fixation in TAPP for Gilbert Type III Inguinal Hernia

Role: collaborator

NCT05206890Recruiting

A Non-interventional Registry Study of Fluzoparib in the Treatment of Ovarian Cancer

Role: collaborator

All 4 trials loaded